Oddity Tech (NasdaqGM:ODD) Q3 2025 Earnings Call November 20, 2025 08:30 AM ET Company ParticipantsOran Holtzman - Co-founder and CEOMaria Lycouris - Investor RelationsCory Carpenter - Internet & Video Games Equity ResearchYoussef Squali - Managing Director and Global Head of Internet and Media Equity ResearchBonnie Herzog - Managing DirectorAnna Lizzul - VP and Equity ResearchAndrew Boon - Managing DirectorLindsay Drucker Mann - CFOScott Schoenhaus - Equity ResearchConference Call ParticipantsBrian Tanquil ...

Oddity Tech (NasdaqGM:ODD) Q3 2025 Earnings Call November 20, 2025 08:30 AM ET Company ParticipantsOran Holtzman - Co-founder and CEOMaria Lycouris - Investor RelationsCory Carpenter - Internet & Video Games Equity ResearchAndrew Boone - Managing DirectorYoussef Squali - Managing Director and Global Head of Internet and Media Equity ResearchBonnie Herzog - Managing DirectorAnna Lizzul - VP and Equity ResearchLindsay Drucker Mann - CFOScott Schoenhaus - Equity ResearchConference Call ParticipantsBrian Tanqui ...

Oddity Tech (NasdaqGM:ODD) Q3 2025 Earnings Call November 20, 2025 08:30 AM ET Speaker2Good morning. Welcome to Oddity's third quarter 2025 earnings conference call. Today's call is being recorded. We have allotted time for prepared remarks and Q&A. At this time, I would like to turn the conference over to Maria Lycouris, Investor Relations for Oddity. Thank you. You may begin.Speaker1Thank you, Operator. I'm joined by Oran Holtzman, Oddity's co-founder and CEO, and Lindsay Drucker Mann, Oddity's global CFO ...

DISCLAIMER This presentation contains estimates and other statistical data made by independent parties and by the Company relating to market size and growth and other data about the Company's industry and estimated total addressable market. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. Neither the Company nor any other person makes any representation as to the accuracy or completeness of such data or undertakes any obligation to ...

Financial Data and Key Metrics Changes - Total net revenues for Q3 2025 increased by 47.5% year-over-year to RMB 998.4 million, up from RMB 677 million in the prior year [11] - Gross profits rose by 51.9% to RMB 780.5 million, with gross margin increasing to 78.2% from 75.9% [11][12] - Net loss narrowed significantly to RMB 70.4 million, improving net loss margin to 7% from 17.9% in the prior year [16] Business Line Data and Key Metrics Changes - Skincare brands saw a remarkable revenue increase of 83.2% year-over-year, contributing 49.2% to total revenue [4][11] - Color cosmetics brands experienced a 25.2% year-over-year revenue increase [11] - Operating loss decreased to RMB 83.6 million from RMB 141.3 million, with operating loss margin improving to 8.4% from 20.9% [15] Market Data and Key Metrics Changes - The beauty market in China is showing signs of recovery, particularly in the skincare category, which is driving overall industry growth [4] - The company noted strong performance in e-commerce channels, with specific products gaining traction during the Double 11 shopping festival [22] Company Strategy and Development Direction - The company is focused on building a competitive brand portfolio anchored in R&D and innovation, aiming for sustainable growth and profitability [4][10] - There is a commitment to optimizing product and channel mix to enhance gross margin and marketing ROI [29] - The company plans to continue investing in innovation while balancing growth with profitability [5][10] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in reaching profitability, highlighting the balance between growth and profitability as a long-term goal [23] - The company anticipates total net revenues for Q4 2025 to be between RMB 1.32 billion and RMB 1.49 billion, reflecting a year-over-year increase of approximately 15% to 30% [18] Other Important Information - The company had cash, restricted cash, and short-term investments of RMB 1.16 billion as of September 30, 2025, down from RMB 1.36 billion at the end of 2024 [17] - Net cash used in operating activities for Q3 2025 was RMB 126.8 million, an improvement from RMB 175.9 million in the prior year [17] Q&A Session Summary Question: Performance during Double 11 Festival and competition from foreign brands - Management indicated that overall performance during Double 11 was in line with expectations, with some brands exceeding them. They noted significant competition from foreign high-end brands, which are struggling with price cuts [20][22][23] Question: Sustaining skincare business growth and improving profitability - Management emphasized the importance of R&D and product innovation as key drivers for sustaining skincare growth. They also highlighted product mix optimization and customer engagement as strategies for improving profitability [27][29] Question: Future expenses and competition in online channels - Management stated that general and administrative expenses are expected to remain stable, with operational leverage as revenue grows. They acknowledged fierce competition in online channels but expressed confidence in their growth strategy driven by R&D and brand building [34][40]

Core Points - Waldencast plc has sold its rights to the "Obagi" trademark in Japan to Rohto Pharmaceutical Co., Ltd. for USD $82.5 million [1] - The transaction is part of Waldencast's strategy to improve its capital structure and maximize shareholder value [5][6] Financial Transactions - Rohto has been licensing the "Obagi" mark since 2002, and royalties from this arrangement accounted for 3% of net revenue for the Obagi Medical business for the fiscal year ended December 31, 2024 [2] - Waldencast has entered into a new credit agreement with Lumina Capital Management for a secured first-lien term loan facility of $225 million, aimed at improving liquidity and supporting brand growth [3][4] - Proceeds from the sale to Rohto will be used to repay a significant portion of the new loan facility, further deleveraging the company's balance sheet [4] Strategic Focus - The company is currently reviewing a range of strategic alternatives to enhance shareholder value, with the recent transactions reflecting this ongoing focus [5] - The CEO of Waldencast expressed that these transactions will substantially strengthen the company's balance sheet while exploring strategic options [6]

Core Insights - Estée Lauder Companies, Inc. has made a strategic investment in XINÚ, a Mexican luxury fragrance brand, marking its first investment in a Latin American company [1][4] - The investment aims to support regional creators and emerging beauty innovators, reflecting Estée Lauder's commitment to discovering new voices in the beauty industry [1][3] Company Overview - XINÚ, founded in 2017, focuses on sensory retail experiences, sustainable craftsmanship, and storytelling-driven fragrance design, blending heritage influences with contemporary artistry [2] - The brand aims to celebrate cultural roots while redefining luxury through authenticity and artistry [2][3] Leadership Statements - Stéphane de La Faverie, CEO of Estée Lauder, emphasized Mexico's role as a source of innovation where culture and design intersect, highlighting XINÚ's embodiment of this spirit [3] - Verónica Peña, co-founder of XINÚ, described the investment as a significant milestone that aligns the brand's vision with global opportunities [3] Investment Strategy - The investment was completed through Estée Lauder's early-stage venture arm, New Incubation Ventures, which focuses on partnering with emerging founders to develop next-generation beauty brands [4] - NIV's strategy targets companies appealing to new demographics and aims to support future growth engines for Estée Lauder [4] Market Reaction - Following the announcement, Estée Lauder's shares traded 0.63% lower at $89.50 [4]

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, which may allow investors to recover losses due to misleading statements regarding product demand and inventory levels [1][3]. Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrances, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [3]. Investigation Details - The investigation is prompted by discrepancies between Coty's claims about strong demand for Prestige fragrances and the reality of overstocked inventory at retailers, indicating a decline in demand for Coty's products [3]. Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations. The company noted a slowdown in cosmetics sales due to various factors, including value-seeking behavior and U.S.-specific issues [4]. - Following the announcement of these results, Coty's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share within a day [4].

Key Takeaways Sally Beauty's Q4 revenues are pegged at $933 million, down 0.2% year over year.Earnings per share are projected at 49 cents, marking a 2% decline.Higher marketing and labor costs offset gains from cost savings and brand refresh efforts.Sally Beauty Holdings, Inc. ((SBH) is likely to register a top and bottom line decline when it reports fourth-quarter fiscal 2025 earnings on Nov. 13. The Zacks Consensus Estimate for revenues is pegged at $933 million, indicating a decrease of 0.2% from the pr ...

Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, with allegations that the company misled investors regarding its inventory and demand for products [1][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrances, color cosmetics, and skin and body care products. Prestige fragrances represent 60% of the company's revenues [3]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and headwinds from previous fiscal year innovations. The company noted a slowdown in cosmetics sales due to value-seeking behavior and U.S.-specific factors [4]. - Following the announcement of these results, Coty's stock price fell by $1.05 per share, a decline of over 21%, dropping from $4.86 to $3.81 per share within a day [4].